Subject: 2nd Eur. Congr. Pharmaceu. Sci. - Announcement

From: <[email-masked]>
Date: Mon, 14 Feb 1994 13:08:00 +0100

* * *  A N N O U N C E M E N T  * * *

-------------------------------------------------------------------------------

                  2nd European Congress of Pharmaceutical Sciences
                        29th September - 1st October, 1994
                                 Berlin, Germany

-------------------------------------------------------------------------------

The 2nd European Congress of Pharmaceutical Sciences will take place in Berlin,
Germany from September 29 to October 1, 1994. The programme will consist of 4
Plenary Trend Lectures and 14 Parallel Symposia on current topics in
pharmaceutical sciences to be presented during three days. Short communications
and poster sessions will complement the programme. The expected number of
participants is approximately 1000.

-------------------------------------------------------------------------------

Programme, registration form and further information can be obtained from:

                              Apothekerhaus
                             Carmerstrasse 3
                               10623 Berlin
                                 Germany

                          Tel: 	(49) 30-3135091
                          Fax: 	(49) 30-3123081

-------------------------------------------------------------------------------

                            Congress Schedule

Thursday September 29, 1994

Plenary Lecture

J. Drews
The evolution of biomedical science and the future of drug design

Parallel Symposium 1
Enzymes as targets for drug development

A.W. Alberts
Recent approaches to cholesterol biosynthesis inhibition

R.W. Hartmann
Selective inhibition of steroidogenic P450 enzymes: 
Current status and future perspectives

Parallel Symposium 2
Drug targeting

D.J.A. Crommelin
Targeting of peptide and protein drugs

H.P. Merkle
New aspects of pharmaceutical dosage forms for
controlled drug delivery of peptides and proteins

Parallel Symposium 3
Alternative methods to animal experimentation

A. Cordier
Strategy of using in vitro tests in preclinical safety testing

B. Garthoff
The use of transgenic animals in drug research

Parallel Symposium 4
Pharmaceutical impact on chronic disease therapy

R. Paoletti
Combined drug therapy and the prevention of cardiovascular diseases

J. Urquhart
Compliance as a major determinant for the success of chronic drug treatment

J.C. Aschoff
Physostigmin for cerebellar ataxia's: The phantasies of a clinical neurologist
and the real problems in developing a legalized therapeutic system (TTS)

Friday September 30, 1994

Plenary Lecture

E. De Clercq
Trends in drug development for the treatment of AIDS

Parallel Symposium 5
Receptor selectivity and drug development

J.-C. Schwartz
Molecular biology of receptors and drug design

T.W. Schwartz
Molecular mechanism of agonists and antagonists on neuropeptide receptors

Parallel Symposium 6
Computer based methods in pharmaceutical sciences

G. Folkers
Modelling of ligand-protein interaction complexes as a basis of drug design

Y.C. Martin
Utility and challenges of 3D databases in new drug discovery

Parallel Symposium 7
Overcoming biological barriers

C. Laboisse
Intestinal cell culture models

H. Lennernas
Gastrointestinal absorption mechanisms: A comparison between animal and 
human models

Parallel Symposium 8
Non invasive techniques in drug development

P. Hartvig
PET-illuminating in vivo drug disposition

C.G. Wilson
Application of gamma scintigraphy to modern dosage form design

M. Rudin
In vivo magnetic resonance imaging and spectroscopy in pharmacological 
research: Applications to drug development and profiling

Parallel Symposium 9
Pharmacoeconomics - a perspective on drug cost and drug benefit

B. Joensson
Health economics - what is it about?

M.F. Drummond
Health economic evaluation and reimbursement of pharmaceuticals

G. Kobelt-Nguyen
Health economics - an industry perspective

Saturday October 1, 1994

Plenary Lectures

J. Feijen
The impact of biomaterials on pharmacists to drug research

Y. Torud
Contributions of European pharmacists to drug research

Parallel Symposium 10
New approaches in drug synthesis

P. Krogsgaard-Larsen
Agonists, partial agonists and antagonists at GABA and glutamate receptors in 
Alzheimer's disease: Chemistry and pharmacology

K.T. Wanner
Chiral N-acyliminium ions as new tools in the asymmetric synthesis of 
CNS-active compounds

Parallel Symposium 11
Antioxidants and cell protection

S. Orrenius
Intracellular oxidative processes and cell killing

C. Galli
Natural antioxidants, lipid peroxidation and platelet/leukocyte functions

Parallel Symposium 12
Prediction of drug metabolism

D.A. Smith
Chemistry and enzymology: Their use in the prediction of human drug metabolism

W. Taeschner
Prediction of genetic variation of drug metabolism

Parallel Symposium 13
Plant metabolites as models for modern drug research

W.F. Fleck
Benzo[a]naphthacenequinones from microorganisms as models of modern drug 
research

W. Kubelka
Constituents of higher plants as models for modern drug research

M. Tanker
Certain Anatolian plants and their constituents influencing drug disposition

Parallel Symposium 14
New opportunities for near infrared (NIR) spectrometry in
pharmaceutical and biomedical analysis

C. van der Vlies
The use of NIR spectrometry in the pharmaceutical control laboratory

M. Josefson
New opportunities with NIR spectrometry in the analysis of dosage forms

R.A. Lodder
NIR-Spectrometric imaging

-------------------------------------------------------------------------------

The above announcement has been submitted to CCL by:

Flemming Steen Jorgensen
Associate professor, Ph.D.

Royal Danish School of Pharmacy
Department of Medicinal Chemistry
Universitetsparken 2
DK-2100 Copenhagen
Denmark

Phone:    +45 35 37 08 50 ext. 378
Fax:      +45 35 37 22 09

If you need more information, you are welcome to contact me on:

[email-masked]

-------------------------------------------------------------------------------